EXEL
Asset Logo

Exelixis, Inc.

πŸ‡ΊπŸ‡Έ NYSE/NASDAQ

πŸ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 22.58%
Annual Growth

5 years average annual growth

🌏

5
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Exelixis, Inc. is an oncology company. The Company is engaged in developing medicines and combination regimens at the forefront of cancer care. It has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma (RCC), for previously treated hepatocellular carcinoma (HCC) and for previously treated, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer (MTC). The Company's other two products are COTELLIC, an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO an oral, non-steroidal, selective blocker of the mineralocorticoid receptor (MR) approved the treatment of hypertension.

πŸ“ˆ Performance

Price History*

+1878.98%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$34.83

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in EXEL

5

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

17 weeks

πŸ’΅ Average investment amount

$683

⏰ Last time a customer invested in EXEL

10 days
EXEL investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

43%

50k - 100k

57%

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

60%

35 - 90

40%
πŸ™‹ Legal gender of investors

Female

60%

Male

40%

Pearlers who invest in EXEL also invest in...

NVIDIA Corporation

NVDA

πŸ™Œ Performance (5Yr p.a)

538.48%

πŸ“Š Share price

$146.67 USD

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

πŸ™Œ Performance (5Yr p.a)

894.82%

πŸ“Š Share price

$198.38 USD

πŸ™Œ Performance (5Yr p.a)

49.77%

πŸ“Š Share price

$228.52 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

1011.75%

πŸ“Š Share price

$167.63 USD

πŸ™Œ Performance (5Yr p.a)

56.01%

πŸ“Š Share price

$102.63 USD

Want more shares? Try these...

πŸ“Š Share price

$3.32 USD

πŸ“Š Share price

$100.97 USD
Compare
Add to watchlist